Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

Nociti V, Cesarano S, Romozzi M, Totaro R, Albanese M, Casalena A, Annovazzi P, Fantozzi R, Tortorella C, Vercellino M, et al.